Medical Education Hub
The University of Texas MD Anderson Cancer Center IOTOX Symposium Treating Immune-Related Adverse Events Integrating Insights from Clinical, Translational and Basic Science 2024
The University of Texas MD Anderson Cancer Center IOTOX Symposium Treating Immune-Related Adverse Events Integrating Insights from Clinical, Translational and Basic Science 2024
Couldn't load pickup availability
The University of Texas MD Anderson Cancer Center IOTOX Symposium Treating Immune-Related Adverse Events Integrating Insights from Clinical, Translational and Basic Science 2024
Include: 3 videos + 1 pdf, size: 8.4 GB
Target Audience: allergy and immunology, internal medicine, and medical oncology, as well as pharmacists, physician associates, and trainees
Information:
The IOTOX Symposium is designed to bring a diverse range of stakeholders together to foster collaboration, share cutting-edge research findings, and discuss treatment advancements in the field of immunotherapy toxicities. The Symposium will provide a platform for attendees to engage in in-depth discussions and attend presentations that highlight new methodologies, emerging technologies, and innovative clinical management strategies. By facilitating network and knowledge exchange, the Symposium seeks to drive scientific progress and translate research into practical treatment options to improve patient outcomes.
Call for Abstracts
We invite faculty, trainees and staff to submit abstracts in the areas of clinical, translational, and basic science research. Submission deadline has been extended. To be considered for oral presentation, submit by Sunday, Sept. 29, 11:59pm.
- Construct the guideline recommendations for each toxicity.
- Identify location and use of national societies guidelines for IOTOX.
- Implement IOTOX guidelines that are vetted by both oncologists and internal medicine specialists.
- Identify patient treatment plans to evaluate difficult patient circumstances as it pertains to IOTOX.
- Employ treatment plans and IOTOX guidelines to all providers including Pharmacists, APPs, Nurses and Trainees.
+ Topics:
Agenda.pdf
November 6 Part 1.mp4
November 6 Part 2.mp4
November 7.mp4
- Detail:
12:00PM – 1:00PM
1:00PM – 1:05PM
David J. Tweardy, MDOverview & Introduction of Keynote Speaker
(NO CE Credit Awarded)
1:05PM – 1:50PM
Padmanee Sharma, MD, PhD
1:50PM – 2:00PM
Moderators: Adi Diab, MD; and Roza Nurieva, PhD
2:00PM – 2:30PM
Yinghong Wang, MD, PhD
2:30PM – 3:00PM
Michael Dougan, MD, PhD
3:00PM – 3:30PM
Adi Diab, MD
3:30PM – 4:00PM
Roza Nurieva, PhD
4:00PM – 5:00PM
5:00PM – 5:15PM
5:15PM – 6:30PM(No CE Credit Awarded)
8:00AM – 8:05AM
Christopher R. Flowers, MD, FASCOOverview & Introduction of Keynote Speaker
(NO CE Credit Awarded)
8:05AM – 8:50AM
Pauline Funchain, MD
8:50AM – 9:00AM
Moderators: Adi Diab, MD; and Roza Nurieva, PhD
9:05AM – 9:10AM
Seyed Javad M. Moghaddam, MD
Kristen Pauken, PhDPanelists for Mouse Studies:
Kristen Pauken, PhD; and Seyed Moghaddam, MD
Panelists for Human Studies:
Sumit Subudhi, MD; and Ala Abudayyeh, MD
Topics to be Discussed:
• What is Heavily Conserved and Readily Modeled
• How to Translate These Findings Clinically
Q&A Session
9:10AM – 9:20AM
Sumit K Subudhi, MD, PhD
Ala Abudayyeh, MD
10:30AM – 10:40AM
Moderators: Bilal A. Siddiqui, MD; and Sebastian T. Wurster MD
10:40AM – 11:00AM
Noah I Hornick, MD, PhD, FAAD
Sebastian T Wurster, MD (Moderator)
11:00AM – 11:10AM
11:10AM – 11:30AM
Nupur Kikani, MD
11:30AM – 11:40AM
11:40AM – 12:00PM
Alexa Meara, MD
12:00PM – 12:10PM
12:10PM – 1:10PM
Moderators: Yinghong (Mimi) Wang, MD, PhD; and Ashley Aaroe, MD
1:10PM – 1:30PM
Bianca Santomasso, MD, PhD
1:30PM – 1:40PM
1:40PM – 2:00PM
Nicolas Palaskas, MD
2:00PM – 2:10PM
2:10PM – 2:30PM
Ajay Sheshadri, MD
2:30PM – 2:40PM
Moderators: Arielle Raugh, PhD; and Synat Keam, PhD
2:40PM – 2:50PM
Matthew J Hadfield, DO
2:50PM – 2:55PM
2:55PM – 3:05PM
Synat Keam Sr., PhD
3:05PM – 3:10PM
3:10PM – 3:20PM
Felipe Soto Lanza, MBBS,MD
3:20PM – 3:25PM
3:25PM – 3:35PM
Naimah Turner, MS
3:35PM – 3:40PM
3:40PM – 3:45PM
Share
